Please login to the form below
INC Research hires former Pfizer senior director
Beatrice Setnik joins CRO as VP, clinical pharmacology
INC Research has appointed former Pfizer senior director Dr Beatrice Setnik as VP, clinical pharmacology.
Setnik had been with pharma giant Pfizer since 2008 serving as senior director, medical development for the company's neuroscience business.
Prior to this she spent several years at Kendle in senior research positions.
In her new role at the contract research organisation (CRO) INC Research she will support the company's early phase business unit, providing scientific direction on matters related to abuse liability for investigational products.
Dr Pierre Geoffroy, VP, early phase at INC Research commented on Dr Setnik's suitability for the role.
"Dr Setnik's extensive knowledge and experience in the area of human abuse liability assessment and risk evaluation, as well as in CNS drug development, clinical trial design and strategic lifecycle management, will be instrumental in furthering the development of our abuse potential capabilities and new scientific growth strategies for early phase clinical research,” said Dr Geoffroy.
Subscribe to our email news alerts
- Pfizer’s RSV vaccine granted MHRA approval to protect infants and older adults
- Novavax’s updated COVID-19 vaccine granted Emergency Use Listing by WHO
- FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies
- Boehringer Ingelheim and IBM announce AI antibody drug discovery partnership
- New blood test to reduce heart attacks and death rates in A&E heart patients
- Clairvoyant commercialisation
No results were found
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
